APXENTA 30MG TAB

About

APXENTA 30MG TAB contains Apixaban, an oral direct factor Xa inhibitor, a type of anticoagulant. It works by selectively and reversibly inhibiting free and clot-bound factor Xa, an enzyme critical in the coagulation cascade responsible for converting prothrombin to thrombin. By inhibiting factor Xa, Apixaban reduces thrombin generation and thrombus formation, thereby preventing blood clots. It is widely used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE). Its predictable pharmacokinetics and lack of need for routine coagulation monitoring make it a convenient and effective option for anticoagulation, offering a significant advantage over traditional anticoagulants.

Uses

• Prevention of stroke in non-valvular atrial fibrillation
• Treatment of deep vein thrombosis (DVT)
• Treatment of pulmonary embolism (PE)
• Prevention of recurrent DVT and PE

Directions For Use

Take orally twice daily with or without food, as prescribed by your doctor. Do not stop taking it without consulting your doctor.

Benefits

• Effective in preventing blood clots.
• Reduces risk of stroke in atrial fibrillation.
• Treats and prevents DVT and PE.
• No routine coagulation monitoring required.
• Predictable anticoagulant effect.
• Lower risk of major bleeding compared to warfarin in some studies.

Side Effects

• Bleeding (e.g., nosebleeds, gum bleeding, bruising)
• Nausea
• Anemia
• Rash
• Hypersensitivity reactions
• Gastrointestinal hemorrhage
• Hematuria
• Epistaxis
• Hematoma
• Increased liver enzymes
• Spinal/epidural hematoma (with neuraxial anesthesia)
• Thrombocytopenia (rare)

Safety Measures

• Alcohol - Limit alcohol intake as it can increase the risk of bleeding, especially gastrointestinal bleeding.
• Pregnancy - Not recommended; potential for fetal harm and increased bleeding risk during pregnancy and delivery.
• Breastfeeding - Not recommended; Apixaban passes into breast milk and may cause bleeding in the infant.
• Liver - Contraindicated in patients with severe hepatic impairment or liver disease associated with coagulopathy.
• Kidney - Use with caution in severe renal impairment; dose adjustment may be necessary, and monitor for bleeding.
• Lung - Used to treat and prevent pulmonary embolism; generally safe for use in patients with lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.